CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 74 filers reported holding CATALYST BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,967,000 | -69.2% | 376,010 | -57.9% | 1.22% | -33.7% |
| Q3 2018 | $9,622,000 | +4.8% | 892,579 | +13.4% | 1.84% | +29.7% |
| Q2 2018 | $9,183,000 | -33.9% | 786,865 | +46.1% | 1.42% | -37.8% |
| Q1 2018 | $13,896,000 | +227.4% | 538,624 | +73.1% | 2.29% | +192.6% |
| Q4 2017 | $4,244,000 | – | 311,175 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |